Some unanswered questions remain, though, about how these drugs would affect addiction. Many people who take GLP-1 drugs to treat obesity or diabetes discontinue them; afterward, their appetite typically returns and they regain the weight they lost. Whether the same rebound would occur with addiction, and what it would mean for someone in recovery to face the roar of craving again, is unknown. Nor is it clear whether the benefits persist over years of continuous use, or whether the brain adapts in ways that dampen those effects.
Иран установил личности виновных в ударе по школе для девочек в Минабе14:56
，这一点在谷歌浏览器下载中也有详细论述
Фото: Игорь Иванко / Коммерсантъ，这一点在体育直播中也有详细论述
В Израиле заявили о гибели организатора покушения на Трампа14:49